Radiolabelled Anti-CD66 Monoclonal Antibody in the Conditioning Regimen Prior to Haematopoietic Stem Cell Transplantation: Phase I Study in Patients With Poor-risk Disease.
Latest Information Update: 20 Jul 2012
At a glance
- Drugs Besilesomab Y 90 (Primary)
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Lymphoma; Myeloma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 02 Feb 2012 New trial record